| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.310 | None | 1.000 | 5 | 0 | 1987 | 2018 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 0.958 | 5 | 0 | 1995 | 2020 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.300 | None | 1.000 | 5 | 0 | 1999 | 2016 | |||||||||
|
ATP synthase F0 subunit 6 | 0.541 | 0.731 |
|
disease | 0.500 | None | 1.000 | 5 | 11 | 1990 | 2020 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.640 | None | 1.000 | 5 | 9 | 1999 | 2015 | |||||||||
|
cytochrome c oxidase III | 0.546 | 0.808 |
|
disease | 0.400 | None | 1.000 | 5 | 9 | 1996 | 2002 | |||||||||
|
NADH dehydrogenase, subunit 5 (complex I) | 0.531 | 0.769 |
|
disease | 0.780 | None | 1.000 | 5 | 9 | 1997 | 2020 | |||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2000 | 2015 | |||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.400 | None | 0.884 | 5 | 0 | 1995 | 2019 | |||||||||
|
telomerase RNA component | 0.471 | 0.846 |
|
disease | 0.700 | None | 1.000 | 5 | 29 | 2001 | 2019 | |||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
disease | 0.370 | None | 0.400 | 5 | 0 | 1999 | 2004 | |||||||||
|
potassium inwardly rectifying channel subfamily J member 18 | 0.722 | 0.346 |
|
disease | 0.700 | limited | 1.000 | 4 | 6 | 2010 | 2016 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 2004 | 2014 | |||||||||
|
immunoglobulin heavy variable 3-21 | 0.780 | 0.192 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2013 | |||||||||
|
immunoglobulin heavy variable 3-21 | 0.780 | 0.192 |
|
disease | 0.310 | None | 1.000 | 4 | 0 | 2007 | 2013 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.320 | None | 1.000 | 4 | 0 | 2002 | 2017 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 1996 | 2004 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2003 | 2010 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2002 | 2009 |